As of 2026-02-07, the Intrinsic Value of TRYP Therapeutics Inc (TRYP.CN) is -0.25 CAD. This TRYP.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.06 CAD, the upside of TRYP Therapeutics Inc is -514.28%.
Based on its market price of 0.06 CAD and our intrinsic valuation, TRYP Therapeutics Inc (TRYP.CN) is overvalued by 514.28%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.25 - -0.25 | -0.25 | -514.28% |
| DDM - Stable | 2.20 - 2.55 | 2.37 | 3855.4% |
| DDM - Multi | 2.49 - 2.05 | 2.26 | 3661.3% |
| Market Cap (mil) | 5.79 |
| Beta | -3.73 |
| Outstanding shares (mil) | 96.42 |
| Enterprise Value (mil) | 8.73 |
| Market risk premium | 5.10% |
| Cost of Equity | 2.33% |
| Cost of Debt | 5.00% |
| WACC | 2.69% |